Jane Hughes

BA Hons, MPH

School of Medicine and Population Health

Research Associate

jane.hughes2@sheffield.ac.uk
+44 114 222 0762

+44 114 222987

2.11, CTRU, The Innovation Centre

Full contact details

Jane Hughes
School of Medicine and Population Health
2.11, CTRU
The Innovation Centre
217 Portobello
Sheffield
S1 4DP

Profile

I am currently a Research Associate on a mixed methods NIHR study - PCAAAS - Patient Centred Abdominal Aortic Aneurysm study - developing and evaluating surveys, workshops and qualitative interviews.

Previously I was a study manager on an NIHR RCT - STOP-OHSS – a multi-centre trial evaluating an intervention for women who develop ovarian hyperstimulation as a result of fertility treatment.

I have also worked as a research associate on a range of studies across several different specialities:

Scottish Minimum Unit Pricing for Alcohol study (SARG) – an evaluation of the MUP for alcohol policy in Scotland.
TIME study – A take-home naloxone intervention multicentre emergency setting feasibility trial.
NIHR funded - The Design, Development, Commissioning and Evaluation of Patient Focused Vascular Services study - (HEDS).
Cancer, Fertility and Me study - developing and evaluating a decision aid for women diagnosed with cancer considering fertility preservation (HEDS).

Before joining ScHARR I was a Clinical Data Manager at the Sheffield University Cancer Clinical Trials Unit – working on a variety of cancer drug clinical trials. I gained an MPH at ScHARR in 2012.

Qualifications: BA (hons) Economics and Geography, PGCE - primary education, MPH - Masters in Public Health, Scharr

Research interests: I am interested in a range of research methodologies - from quantitative surveys to qualitative interviews - in the evaluation of health outcomes in public health research.

Publications

Show: Featured publications All publications

Featured publications

This person does not have any publications available.

All publications

Journal articles

Field B, Lumley E, Hughes J, Elstone A, Hall J, Nasim A, Stansby G & O’Cathain A (2025) What Help do Men under Abdominal Aortic Aneurysm Surveillance Want to Manage Anxiety? A Qualitative Interview Study. European Journal of Vascular and Endovascular Surgery.
Lumley E, Hughes J, Elstone A, Hall J, MacGregor-Smith N, Michaels J, Nasim A, Radley S, Shackley P, Stansby G , Wood E et al (2024) Managing anxiety in men undergoing surveillance in the NHS abdominal aortic aneurysm screening programme: A survey of screening staff in England. Journal of Vascular Nursing.
Snooks HA, Jones JK, Bell FB, Benger JR, Black SL, Dixon S, Edwards A, Emery H, Evans BA, Fuller GW , Goodacre S et al (2024) Take-home naloxone administered in emergency settings: feasibility of intervention implementation in a cluster randomized trial. BMC Emergency Medicine, 24. View this article in WRRO
Sampson FC, Hughes J, Long J, Buykx P, Goodacre SW, Snooks H, Edwards A, Evans B, Jones J, Moore C & Johnston S (2024) Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff. BMC Emergency Medicine, 24(1). View this article in WRRO
Jones G, Brown Hajdukova E, Hanna E, Duncan R, Gough B, Hughes J, Hughes D, Ashworth F, Prevot J, Drabwell J , Solis L et al (2021) It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders. Qualitative Research in Medicine and Healthcare, 4(3), 117-131. View this article in WRRO
Jones M, Bell F, Benger J, Black S, Buykx P, Dixon S, Driscoll T, Evans B, Edwards A, Fuller G , Goodacre S et al (2020) Protocol for Take-home naloxone In Multicentre Emergency (TIME) settings: feasibility study. Pilot and Feasibility Studies, 6(1). View this article in WRRO
Rooney G, Aber A, Phillips P, Hughes J, Keetharuth AD, Walters S, Jone G & Michaels J (2020) Electronic personal assessment questionnaire for vascular patients (ePAQ-VAS) development and validity. British Journal of Surgery. View this article in WRRO
Wickramasekera N, Howard A, Philips P, Rooney G, Hughes J, Wilson E, Aber A, Michaels J & Shackley P (2020) Author response to: Comment on: Strength of public preferences for endovascular or open aortic aneurysm repair. British Journal of Surgery, 107(5), 613-614.
Wickramasekera N, Howard A, Philips P, Rooney G, Hughes J, Wilson E, Aber A, Michaels J & Shackley P (2019) Strength of public preferences for endovascular or open aortic aneurysm repair. British Journal of Surgery, 106(13), 1775-1783. View this article in WRRO
Mahmoodi N, Bekker HL, King NV, Hughes J, Jones GL & Team CFMR (2018) Are publicly available internet resources enabling women to make informed fertility preservation decisions before starting cancer treatment: An environmental scan? 11 Medical and Health Sciences 1117 Public Health and Health Services. BMC Medical Informatics and Decision Making, 18(1). View this article in WRRO
Vogt KS, Hughes J, Wilkinson A, Mahmoodi N, Skull J, Wood H, McDougall S, Slade P, Greenfield DM, Pacey A , Ledger W et al (2018) Preserving fertility in women with cancer (PreFer): Decision‐making and patient‐reported outcomes in women offered egg and embryo freezing prior to cancer treatment. Psycho-Oncology.
Jones G, Hughes J, Mahmoodi N, Smith E, Skull J & Ledger W (2017) What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?. Human Reproduction Update, 23(4), 433-457.
Jones GL, Hughes J, Mahmoodi N, Greenfield D, Brauten-Smith G, Skull J, Gath J, Yeomanson D, Baskind E, Snowden JA , Jacques RM et al (2017) Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol. BMJ Open, 7(3). View this article in WRRO
Jones GL, Jacques RM, Thompson J, Wood HJ, Hughes J, Ledger W, Alazzam M, Radley SC & Tidy JA (2016) The impact of surgery for vulval cancer upon health-related quality of life and pelvic floor outcomes during the first year of treatment: a longitudinal, mixed methods study. Psycho-Oncology, 25(6), 656-662. View this article in WRRO
MacInnes E, Erskine S, Collins K, Hughes J, Wilkinson J, Haines R, Cook J & Wyld L (2012) 141. Factors influencing risk management choices (risk reducing surgery or screening) in women at high familial breast cancer risk. European Journal of Surgical Oncology, 38(9), 778-779.
Erskine S, Surgey E, Collins K, Hughes J, Wilkinson J, Haines D, Cooke J & Wyld L (2010) Psychosocial and physical outcomes for women at high familial breast cancer risk. European Journal of Surgical Oncology (EJSO), 36(11), 1107-1107.
Hughes J, Lumley E, Elstone A, Hall J, Michaels J, Nasim A, Radley S, Shackley P, MacGregor Smith N, Stansby G , Wood E et al () Psychosocial problems caused by abdominal aortic aneurysm surveillance: A cross-sectional survey. Journal of Medical Screening.
Hughes J, Sampson FC, Buykx P, Long J, Edwards A, Evans BA, Goodacre S, Jones MB, Moore C & Snooks HA () Would provision of Take Home Naloxone Kits by Emergency Medical Services be perceived as acceptable to people at risk of opioid overdose? A qualitative study. Prehospital Emergency Care, 1-15.
Buykx P, Perkins A, Hughes J, Livingston W, Boyd J, Perman‐Howe P, Johnston A, McCarthy T, McLean A, Wright A , Little S et al () The impact of Scotland's minimum unit pricing for alcohol policy on people accessing services for alcohol dependence: A difference‐in‐difference structured interview study. Drug and Alcohol Review.
Snooks H, Benger J, Bell F, Black S, Dixon S, Emery H, Evans BA, Fuller G, Hoskins R, Hughes J , Jones J et al () Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT. Health Technology Assessment, 1-69.
Livingston W, Holmes J, Hughes J, Buykx P, Perkins A, Wright A, Gardiner K, Yannoulis Y, Johnston A & Maclean A () Expected and actual responses to minimum unit pricing (MUP) for alcohol of people drinking at harmful levels in Scotland. Drugs: Education, Prevention and Policy, 1-10.
Hughes J, Livingston W, Buykx P, Johnston A, Little S, McCarthy T, McLean A, Perkins A, Wright A & Holmes J () Views on minimum unit pricing for alcohol before its introduction among people with alcohol dependence in Scotland: A qualitative interview study. Drug and Alcohol Review.
Jones GL, Moss RH, Darby F, Mahmoodi N, Phillips B, Hughes J, Vogt KS, Greenfield DM, Brauten-Smith G, Gath J , Campbell T et al () Cancer, Fertility and Me: Developing and Testing a Novel Fertility Preservation Patient Decision Aid to Support Women at Risk of Losing Their Fertility Because of Cancer Treatment. Frontiers in Oncology, 12.

Conference proceedings papers

Emery H, Snooks H, Jones J, Benger J, Driscoll T, Edwards A, Evans BA, Fuller G, Hoskins R, Hughes J , John A et al (2023) EP09 Feasibility of methods and intervention for administration of take-home naloxone in emergency settings: a cluster randomised trial. 999 EMS Research Forum 2023 meeting abstracts
Sampson FC, Hughes J, Long J, Buykx P & Snooks H (2022) PP39 Emergency service provider perspectives of feasibility and acceptability of emergency services distribution of take home naloxone. Emergency Medicine Journal, Vol. 39(9) (pp e5.33-e5.33)
Hughes J, Sampson FC, Long J, Buykx P & Snooks H (2022) EP12 Emergency services provision of take home naloxone to people at risk of opiate overdose: perspectives of potential recipients – a qualitative study. Emergency Medicine Journal, Vol. 39(9) (pp e5.4-e5.4)
Jones GL, Vogt K, Darby F, Mahmoodi N, Hughes J, Greenfield D, Skull J, Lane S, Brauten-Smith G, Yeomanson D , Baskind NE et al (2018) Experience of developing and evaluating a fertility preservation patient decision aid for teenage and adult women with cancer for use in oncology settings, UK (The Cancer, Fertility and Me study). PSYCHO-ONCOLOGY, Vol. 27 (pp 45-45)
MacInnes E, Erskine S, Collins K, Hughes J, Wilkinson J, Cook J, Walters S & Wyld L (2018) Experiences of women and partners of women at increased familial breast cancer risk: A qualitative study of the impact upon partnerships. European Journal of Surgical Oncology, Vol. 44(6) (pp 904-905)
MacInnes E, Erksine S, Collins K, Hughes J, Wilkinson J, Cook J, Walters S & Wyld L (2018) Views and experiences of MRI breast screening in women at increased familial breast cancer risk. European Journal of Surgical Oncology, Vol. 44(6) (pp 905-906), 18 June 2018 - 19 June 2018. View this article in WRRO
Jones G, Hughes J, Mattick E, Poku E, Mahmoodi N, Skull J & Ledger W (2016) What factors influence the decision-making process for women with cancer contemplating fertility preservation? A systematic review. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 123 (pp 70-71)

Preprints

Sampson FC, Hughes J, Long J, Buykx P, Goodacre SW, Snooks H, Edwards A, Evans B, Jones J, Moore C & Johnston S (2023) Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff, Research Square Platform LLC.
Jones M, Bell F, Benger J, Black S, Buykx P, Dixon S, Driscoll T, Evans B, Edwards A, Fuller G , Goodacre S et al () Protocol for Take home naloxone In Multicentre Emergency setting (TIME): Feasibility Study, Research Square Platform LLC.
Jones M, Bell F, Benger J, Black S, Buykx P, Dixon S, Driscoll T, Evans B, Edwards A, Fuller G , Goodacre S et al () Protocol for Take home naloxone In Multicentre Emergency setting (TIME): Feasibility Study, Research Square Platform LLC.

Research group: HSRU